Connect Sign In
A lot has changed in laboratory medicine during the last 100 years. To celebrate Lab Week 2022, here are five resources that examine the past, present, and future of medical laboratory science.
ARUP was among a few blood centers that contributed COVID-19 convalescent plasma (CCP) to a national clinical trial that found a >50% reduction in risk of hospitalization with early CCP treatment.
ARUP’s video entry in the ASCP 2022 Back to the Lab Photo and Video Contest takes a humorous look at just how much laboratory standards have changed in the last few decades.
For 100 years, forward-thinking medical laboratory professionals have pioneered new concepts in diagnostic medicine. Now it’s your turn.
ARUP’s next generation sequencing (NGS) tests are now faster and more precise thanks to the launch of Rio, a new world-class bioinformatics pipeline and analytics platform.
High-volume laboratory testing just got better and faster at ARUP with the addition of a state-of-the-art Roche chemistry and immunoassay platform that is at the center of ARUP’s Automated Core Lab.
Join us for a look at ARUP’s accomplishments in scientific innovation and meet our committed scientists, laboratory professionals, and healthcare advisory consultants who make ARUP an industry leader.
ARUP President and Chief Medical Officer Tracy George, MD, wants to establish a multidisciplinary, multinational network of centers focused on mast cell diagnosis, therapy, and education.
Researchers at ARUP Laboratories made significant contributions to the advancement of laboratory medicine in 2021 as coauthors of more than 150 peer-reviewed articles.
Two years into the COVID-19 pandemic, when the highly contagious Omicron variant of SARS-CoV-2 has infected millions in the United States alone, most of us have some immunity against the virus.
ARUP Transfusion Medicine has partnered with machine-learning experts at the U of U to develop and validate a method that can predict the need for transfusion during cardiothoracic surgery.
PacBio and ARUP Laboratories announced they are collaborating on a study intended to evaluate whether the solve rate for rare disease cases can be increased.
